Industry

 Domain Therapeutics Receives a Single Digit Multimillion Development Milestone Payment from Merck for M1069 Clinical Development in Immuno-Oncology

A2a/A2b antagonist candidate, M1069, jointly discovered by Domain Therapeutics and Merck entered into a first-in-human study to investigate the safety, tolerability, PK/PD and clinical activity in patients with metastatic or locally advanced unresectable solid tumors This drug candidate is the first out of Domain’s pipeline to reach clinical development stage in immuno-oncology. STRASBOURG, France & … [Read more…]

Organ-on-a-Chip Global Markets Report 2022: Drug Discovery and Development, Toxicological Research, & Physiological Model Development – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Organ-on-a-Chip: Global Markets” report has been added to ResearchAndMarkets.com’s offering. The scope of this report covers various types of products available in the organ-on-a-chip market and potential application sectors in various industries. The organ-on-a-chip market is broken down into various segments. An organ-on-a-chip is a type of artificial organ that possesses the capability … [Read more…]

agilon health Appoints Denise Zamore as Chief Legal Officer

Zamore brings extensive legal expertise to agilon within the provider and health plan sectors AUSTIN, Texas–(BUSINESS WIRE)–agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced the appointment of Denise Zamore as the company’s first Chief Legal Officer and Secretary to the agilon health Board of Directors … [Read more…]

MMS Holdings Partners with Lindsay Goldberg for Its Next Stage of Growth

The partnership will help MMS expand its award-winning services to pharma and biotech companies and extend MMS’ leadership in data-focused clinical research services CANTON, Mich.–(BUSINESS WIRE)–MMS Holdings Inc. (“MMS” or the “Company”), a leading data-focused contract research organization (“CRO”), today announced that Lindsay Goldberg, a leading family and founder-focused private equity firm, has completed an … [Read more…]

World Hope International Partners With My Medic™ to Donate $500,000 in Individual First Aid Kits to Ukrainian First Responders

ARLINGTON, Va.–(BUSINESS WIRE)–Global nonprofit World Hope International (WHI) has partnered with first-aid supplies and training company My Medic™ to supply 3,000 first aid kits, valued at over $500,000 USD, to emergency first responders who are treating individuals injured as a result of the war in Ukraine. Created by My Medic as an essential trauma kit, … [Read more…]

SonALAsense Achieves Significant Clinical, Growth and Funding Milestones Toward its Mission to Soundly Defeat Cancer

Company has received Safe to Proceed letters from FDA for two clinical trials in life-threatening brain tumors, DIPG trial is open and actively recruiting, it has expanded its executive leadership team and scientific advisory board and completed a Series B funding round. OAKLAND, Calif.–(BUSINESS WIRE)–#DIPG—SonALAsense, a pioneer in the development of SONALA-001 and sonodynamic therapy … [Read more…]

Siemens Healthineers and The Ohio State University Wexner Medical Center Announce Strategic Partnership Focused on Personalized Medicine and Increased Access to High Quality Healthcare

– Ohio State Wexner Medical Center and Siemens Healthineers have committed to a new strategic relationship to bring the most advanced imaging and treatment technologies from Siemens Healthineers to Ohio State patient care and research centers and the surrounding communities. – The partnership: Provides advanced imaging and cutting-edge radiation oncology modalities at Outpatient Care West … [Read more…]

ENDRA Life Sciences Enhances TAEUS® System Intellectual Property Portfolio with Issuance of 28th U.S. Patent

ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA #NAFLD—ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the United States Patent and Trademark Office has issued a new ENDRA patent, U.S. Patent No. 11369272 (the ‘272 patent) titled “Broadband Applicator for Thermoacoustic Signal Generation.” The ‘272 patent protects TAEUS’ radiofrequency (RF) applicator … [Read more…]

NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe

— Combines NewAmsterdam’s lead clinical program obicetrapib with Menarini’s deep cardiovascular disease and regional expertise — — Total deal value of over €1 billion; including €142.5 million upfront payment and committed R&D funding plus potential milestones and double-digit royalties on net product sales in Europe — — Obicetrapib is a next-generation oral, low-dose and once-daily … [Read more…]

Apnimed Granted FDA Fast Track Designation for AD109, a Novel First-in-Class Oral Pharmacologic Combination for the Treatment of Obstructive Sleep Apnea (OSA)

— Additional Phase 2b data evaluating AD109 as potential treatment for OSA anticipated in Q3 2022 — AD109 Phase 3 development program expected to be initiated in late 2022 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders, announced today that the … [Read more…]